Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Lianluo Smart (LLIT) Competitors

LLIT vs. ICAD, GUTS, MGRM, MBOT, SRTS, INO, TELA, NVNO, NSPR, and APYX

Should you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include iCAD (ICAD), Fractyl Health (GUTS), Monogram Orthopaedics (MGRM), Microbot Medical (MBOT), Sensus Healthcare (SRTS), Inovio Pharmaceuticals (INO), TELA Bio (TELA), enVVeno Medical (NVNO), InspireMD (NSPR), and Apyx Medical (APYX).

Lianluo Smart vs. Its Competitors

icad (NASDAQ:ICAD) and Lianluo Smart (NASDAQ:LLIT) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability, community ranking and analyst recommendations.

24.6% of icad shares are owned by institutional investors. Comparatively, 28.8% of Lianluo Smart shares are owned by institutional investors. 10.3% of icad shares are owned by insiders. Comparatively, 22.9% of Lianluo Smart shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Lianluo Smart has a net margin of 0.00% compared to icad's net margin of -26.63%. Lianluo Smart's return on equity of 0.00% beat icad's return on equity.

Company Net Margins Return on Equity Return on Assets
icad-26.63% -15.03% -11.77%
Lianluo Smart N/A N/A N/A

In the previous week, icad had 4 more articles in the media than Lianluo Smart. MarketBeat recorded 4 mentions for icad and 0 mentions for Lianluo Smart. icad's average media sentiment score of 0.95 beat Lianluo Smart's score of 0.00 indicating that icad is being referred to more favorably in the media.

Company Overall Sentiment
icad Positive
Lianluo Smart Neutral

Lianluo Smart has lower revenue, but higher earnings than icad.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
icad$19.61M5.17-$5.62M-$0.19-19.42
Lianluo Smart$380K66.21-$4.45MN/AN/A

icad received 124 more outperform votes than Lianluo Smart when rated by MarketBeat users. However, 70.27% of users gave Lianluo Smart an outperform vote while only 59.84% of users gave icad an outperform vote.

CompanyUnderperformOutperform
icadOutperform Votes
228
59.84%
Underperform Votes
153
40.16%
Lianluo SmartOutperform Votes
104
70.27%
Underperform Votes
44
29.73%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
icad
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Lianluo Smart
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

icad has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, Lianluo Smart has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500.

Summary

Lianluo Smart beats icad on 8 of the 14 factors compared between the two stocks.

Get Lianluo Smart News Delivered to You Automatically

Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LLIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LLIT vs. The Competition

MetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$25.16M$239.32M$5.22B$8.55B
Dividend YieldN/AN/A5.38%4.21%
P/E RatioN/A5.4125.8019.17
Price / Sales66.2171.05414.37108.91
Price / CashN/A196.1235.3855.76
Price / Book-19.2910.487.925.76
Net Income-$4.45M-$26.39M$3.15B$248.88M

Lianluo Smart Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LLIT
Lianluo Smart
N/A$11.38
+0.9%
N/A+1,266.5%$25.16M$380K0.006
ICAD
iCAD
0.9765 of 5 stars
$3.95
+0.8%
N/A+159.9%$108.51M$19.53M-30.38140Positive News
Short Interest ↓
GUTS
Fractyl Health
2.3255 of 5 stars
$2.16
-25.0%
$11.00
+409.3%
-52.5%$105.79M$60K-0.18102News Coverage
Positive News
Gap Up
High Trading Volume
MGRM
Monogram Orthopaedics
2.3697 of 5 stars
$2.68
+1.9%
$5.40
+101.5%
+22.2%$95.64M$365.00K-5.7028Positive News
MBOT
Microbot Medical
2.1825 of 5 stars
$2.60
+4.4%
$9.00
+246.2%
+131.7%$94.58MN/A-3.2520Positive News
SRTS
Sensus Healthcare
1.4339 of 5 stars
$5.13
+2.6%
$11.67
+127.4%
-9.6%$84.36M$39.49M12.8340News Coverage
Analyst Downgrade
INO
Inovio Pharmaceuticals
3.3214 of 5 stars
$2.25
+1.4%
$9.75
+333.3%
-75.8%$82.52M$283.10K-0.71320News Coverage
TELA
TELA Bio
2.3944 of 5 stars
$1.92
+3.2%
$7.25
+277.6%
-69.7%$75.95M$71.22M-1.14120
NVNO
enVVeno Medical
0.1121 of 5 stars
$4.31
-2.7%
N/A-19.0%$75.58MN/A-3.3419
NSPR
InspireMD
2.6911 of 5 stars
$2.44
+1.7%
$4.50
+84.4%
-2.4%$74.75M$7.03M-3.2550
APYX
Apyx Medical
2.7016 of 5 stars
$1.82
+5.2%
N/A+44.9%$68.79M$47.29M-2.19270Positive News
Short Interest ↓
Gap Up

Related Companies and Tools


This page (NASDAQ:LLIT) was last updated on 6/22/2025 by MarketBeat.com Staff
From Our Partners